University Hospital Cologne
Department of Nuclear Medicine (278023)
Specialized in: nuclear medicine
The Department of Nuclear Medicine at the University Hospital Cologne under the direction of Prof. Dr. med. Alexander Drzezga offers the entire spectrum of diagnosis and treatment in the field of nuclear medicine. The main objective of the department is to achieve the highest possible diagnostic result and treatment effect with a minimal strain exerted on the patient.
The range of medical services of the department includes:
- Imaging diagnosis of oncological diseases by means of conventional (SPECT) and modern multimodal methods (PET-CT)
- Diagnosis of neurodegenerative diseases (Alzheimer’s disease, Parkinson’s disease) by means of the most advanced methods of molecular imaging
- Diagnosis and treatment of thyroid diseases
- Modern forms of diagnosis and treatment of prostatic cancer: the cutting-edge tumor imaging by means of PSMA-PET/CT (PSMA: prostate specific membrane antigen) with the use of markers [68Ga] PSMA and [18F] PSMA enables the high quality imaging diagnosis of prostate tissues (also at PSA level lower 1 ng/ml). The PSMA-binding molecule mark by a therapeutically effective irradiator ([177Lu]PSMA) can be used as a form of modern therapy.
- Radionuclide therapy for other oncological diseases
- Peptide radioreceptor therapy (PRRT) for neuroendocrine diseases
- Selective internal radiation therapy (SIRT) for liver tumors / metastases
- Therapies, e.g. MIGB-therapy for neuroblastoma and pheochromocytoma radioimmunotherapy for lymphoma
- Cologne, Germany